High-dose chemotherapy for chronic lymphocytic leukemia: Eligibility, timing, and benefit?
- 1 February 1998
- journal article
- Published by Elsevier
- Vol. 9 (2) , 131-132
- https://doi.org/10.1023/a:1008259428364
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Hematopoietic stem cell transplantation in chronic lymphocytic leukemia: A report of 12 patients from a single institutionAnnals of Oncology, 1998
- Allogeneic blood or marrow transplantation for chronic lymphocytic leukaemia: timing of transplantation and potential effect of fludarabine on acute graft‐versus‐host diseaseBritish Journal of Haematology, 1997
- HLA-Identical Sibling Bone Marrow Transplantation in Younger Patients with Chronic Lymphocytic LeukemiaAnnals of Internal Medicine, 1996
- Advances in the biology and treatment of B-cell chronic lymphocytic leukemiaBlood, 1995
- Cyclosporin a Inhibits Cytokine-Induced Proliferation in B-Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 1994
- Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemiaBlood, 1993
- Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agentBlood, 1993
- VH gene rearrangement events can modify the immunoglobulin heavy chain during progression of B-lineage acute lymphoblastic leukemia [see comments]Blood, 1992